Stock A268600 CELLIVERY THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Cellivery Therapeutics, Inc.

Equities

A268600

KR7268600004

End-of-day quote Korea S.E.
Other stock markets
 04:30:00 23/03/2023 am IST 		5-day change 1st Jan Change
6,680 KRW -29.91% Intraday chart for Cellivery Therapeutics, Inc. -.--% -.--%
2023 Cellivery Therapeutics, Inc.(KOSDAQ:A268600) dropped from S&P Global BMI Index CI
2021 Cellivery Therapeutics, Inc. acquired Ajin Clean Co., Ltd. from SVAJ Holdings for KRW 14.2 billion. CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Cellivery Therapeutics, Inc.(KOSDAQ:A268600) dropped from S&P Global BMI Index
CI
Cellivery Therapeutics, Inc. acquired Ajin Clean Co., Ltd. from SVAJ Holdings for KRW 14.2 billion.
CI
Cellivery Therapeutics, Inc. agree to acquire Ajin Clean Co., Ltd. for KRW 14.9 billion.
CI
Cellivery Therapeutics, Inc. announced that it has received KRW 38.9997004 billion in funding
CI
Cellivery Therapeutics to Raise Nearly $17 Million Through Stock Sale
MT
Cellivery Therapeutics, Inc. announced that it expects to receive KRW 38.9997004 billion in funding
CI
Cellivery Therapeutics to Raise $13 Million from Stock Offering
MT
Cellivery Therapeutics, Inc. announced that it has received KRW 43.9988081 billion in funding from a group of investors
CI
Cellivery Therapeutics, Inc. announced that it expects to receive KRW 43.9988081 billion in funding from a group of investors
CI
Cellivery Therapeutics, Inc.(KOSDAQ:A268600) added to S&P Global BMI Index
CI
Cellivery Therapeutics, Inc has completed an IPO in the amount of KRW 28.5 billion.
CI
Cellivery Therapeutics, Inc has filed an IPO.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A268600 Stock
  4. News Cellivery Therapeutics, Inc.